- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01468402
Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma
November 8, 2011 updated by: Eduardo Zlotnik, Hospital Israelita Albert Einstein
The purpose of this study is to determine predictive factors in the pelvic magnetic resonance in the response of arterial embolization of uterine leiomyoma.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study followed symptomatic premenopausal women with uterine leiomyoma who underwent uterine artery embolization (UAE).
Treatment was accompanied by magnetic resonance imaging of both the volume of the entire uterus and the leiomyomas one month before and six months after UAE.
This patients were treated at the Uterine Leiomyoma Sector of the Department of Obstetrics and Gynecology, Medicine College of the University of São Paulo.
In this study, the investigators examined 179 leiomyomas in 50 patients.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05652 - 900
- Hospital Israelita Albert Einstein
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women from the Leiomyoma Service, with eligible criteria and chose this kind of treatment between september 2008 and march 2009.
Description
Inclusion Criteria:
- ultrasound diagnosis of uterine leiomyoma
- presence of symptoms (menorrhalgia and/or pelvic pain)
- indication for UAE(the desire to keep the uterus and/or contraindications for surgery).
Exclusion Criteria:
- malignant genital neoplasms
- pelvic inflammatory disease
- allergy to iodinated contrast
- coagulopathy, renal failure
- vasculitis
- pelvic irradiation
- pregnancy
- subserosal leiomyoma with a pedicle smaller than 50% of diameter of the fibroid.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Magnetic Resonanse Image
The leiomyomas were evaluated individually.
MR was used to evaluate morphology: the radiological dimension(s) of the leiomyoma and uterus and the volume.
The number of leiomyoma fibroid, and their location in the myometrium was classified.
Perfusion and the characterization of the T2 signal were also evaluated.
|
The leiomyomas were evaluated individually.
MR was used to evaluate morphology: the radiological dimension(s) of the leiomyoma and uterus and the volume.
The number of leiomyoma fibroids was determined, and their location in the myometrium.
Perfusion and the characterization of the T2 signal were also evaluated.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Leiomyoma reduction in patients who underwent uterine artery embolization
Time Frame: One month before(baseline) and six month after the embolization
|
Use the magnetic resonanse to evaluate factors that predicted leiomyoma reduction in patients who underwent uterine artery embolization
|
One month before(baseline) and six month after the embolization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Eduardo Zlotnik, Hospital Israelita Albert Einstein
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Affonso BB, Nasser F, de Jesus Silva SG, Silva MC, Zlotnik E, de Lorenzo Messina M, Baracat EC. [Strategies for reduction of exposure to ionizing radiation in women undergone to uterine fibroid embolization]. Rev Bras Ginecol Obstet. 2010 Feb;32(2):77-81. Portuguese.
- Nasser F, Affonso BB, de Jesus-Silva SG, Coelho Dde O, Zlotnik E, Messina Mde L, Baracat EC. [Uterine fibroid embolization in women with giant fibroids]. Rev Bras Ginecol Obstet. 2010 Nov;32(11):530-5. doi: 10.1590/s0100-72032010001100003. Portuguese.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
April 1, 2009
Study Completion (Actual)
August 1, 2009
Study Registration Dates
First Submitted
October 23, 2011
First Submitted That Met QC Criteria
November 8, 2011
First Posted (Estimate)
November 9, 2011
Study Record Updates
Last Update Posted (Estimate)
November 9, 2011
Last Update Submitted That Met QC Criteria
November 8, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIAE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exposure to Magnetic Field
-
Saint Luke's Health SystemCompletedMagnetic Field Exposure
-
RWTH Aachen UniversityInstitute for Technical and Macromolecular Chemistry, RWTH Aachen UniversityTerminatedExposure to Magnetic Field | Hypotension During Dialysis | Disturbance; Balance, FluidGermany
-
Rigshospitalet, DenmarkCompletedChildren, Only | Temperature Change, Body | Magnetic Field ExposureDenmark
-
Nova Southeastern UniversityRecruitingPeripheral Arterial Disease | Arterial Stiffness | Magnetic Field ExposureUnited States
-
Istituto Ortopedico RizzoliCompletedPain | ACL Injury | Magnetic Field ExposureItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedPrematurity | Sedation Complication | Magnetic Field ExposureItaly
-
Helmholtz Centre for Environmental Research - UFZDuke University; Seoul National University; University Hospital, AntwerpNot yet recruitingExposure to PollutionGermany
-
Boise State UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedExposure to HerbicidesUnited States
-
Environmental Protection Agency (EPA)CompletedExposure to PollutionUnited States
-
Université de MontréalCompletedExposure to Pollution
Clinical Trials on Magnetic Resonance Image
-
Ming KuangUnknownHepatocellular CarcinomaChina
-
Tri-Service General HospitalCompleted
-
Daegu Catholic University Medical CenterCompleted
-
GE HealthcareTerminatedTraumatic Brain InjuryUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityTaihe Hospital; 215 Hospital of Shaanxi NI; Baoji Zhongxin HospitalRecruiting
-
Nanjing University of Traditional Chinese MedicineHealth Science Center of Xi'an Jiaotong University; Yuncheng First HospitalNot yet recruitingCoronary Heart Disease | ImageChina
-
Nanjing University of Traditional Chinese MedicineHealth Science Center of Xi'an Jiaotong University; The 2rd School of Medicine...Not yet recruitingCarotid Artery Stenosis | ImageChina
-
Nanjing University of Traditional Chinese MedicineHealth Science Center of Xi'an Jiaotong University; Yuncheng First HospitalNot yet recruitingHeart Valve Diseases | ImageChina
-
Stanford UniversityNational Institutes of Health (NIH)Active, not recruitingBreast Cancer | Metastatic Breast CancerUnited States